Latest Asx News

Syntara Limited’s lead drug candidate SNT-5505 has secured FDA Fast Track designation, expediting its development for treating myelofibrosis, a rare and serious blood cancer with limited therapies.

Golden Horse Minerals has reported exceptional deep drilling results at its Hopes Hill project, revealing a significant high-grade gold intercept well below the historic pit floor and confirming a large mineralised system. Plans are underway to accelerate drilling and expand exploration efforts.

Theta Gold Mines has landed a US$35 million loan from South Africa’s Industrial Development Corporation, marking a key funding milestone for its TGME Underground Gold Mine Project.

Pure Foods Tasmania has raised $100,000 through a share placement and appointed directors to new operational roles aimed at driving sales growth and improving cost efficiency.

AnteoTech Ltd has completed a strategic review that refocuses its business on commercialising existing products, delivering $1.6 million in annual cost savings and expanding its sales pipeline in battery and life sciences markets.

Opyl Limited unveils a bold strategic pivot to enhance its AI-driven drug discovery platform, leveraging a vast proprietary dataset and leadership upgrades to redefine clinical trial innovation.

Yojee Limited and SmartClear have completed technical verification of their MOSAIC platform, a next-generation freight forwarding and customs messaging solution compliant with Australian and New Zealand customs regulations. This milestone sets the stage for a strategic partnership aimed at transforming logistics technology in the region.

Sunshine Metals has reported further shallow, high-grade gold intersections at its Liontown prospect, advancing plans for a resource upgrade and mining studies. The latest drilling results reinforce the company’s strategy to rapidly develop oxide gold resources near surface.

Argenica Therapeutics faces a clinical hold from the US FDA on its stroke drug trial application, though its Australian Phase 2 study remains unaffected and on track.

Stavely Minerals has launched a new drilling campaign at its Fairview North gold prospect, aiming to validate a major mineralised trend linking gold and copper-silver deposits in western Victoria.

Botanix Pharmaceuticals has secured a US$30 million debt facility from Kreos Capital, bolstering its financial position to commercialize Sofdra™ and pursue platform expansion opportunities.

Optiscan Imaging Ltd has launched InSpecta™, a cutting-edge microscopic imaging device tailored for veterinary medicine, marking its strategic entry into a booming $12 billion US market. The device promises to revolutionize diagnostics and treatment for companion animals with real-time, non-invasive imaging.